Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-07 1:39 pm Sale | 2025-10-31 | 13G | Aptevo Therapeutics Inc. APVO | BANK OF AMERICA CORP BAC | 5 0.000% | -27,459 (-99.98%) | Filing History |
| 2025-10-06 4:26 pm Purchase | 2025-09-30 | 13G | Aptevo Therapeutics Inc. APVO | BANK OF AMERICA CORP BAC | 27,463 15.000% | 27,463 (New Position) | Filing History |
| 2025-09-17 5:26 pm Purchase | 2025-09-16 | 13G | Aptevo Therapeutics Inc. APVO | Point72 Asset Management, L.P. | 16,664 9.100% | 16,664 (New Position) | Filing History |
| 2025-08-14 6:59 pm Sale | 2025-08-14 | 13G | Aptevo Therapeutics Inc. APVO | L1 Capital Global Opportunities Master Fund, Ltd. | 9,128 4.990% | -6,706 (-42.35%) | Filing History |
| 2025-08-14 2:00 pm Purchase | 2025-06-30 | 13G | Aptevo Therapeutics Inc. APVO | CVI Investments, Inc. | 19,880 9.900% | 19,880 (New Position) | Filing History |
| 2025-08-13 06:28 am Purchase | 2025-06-30 | 13G | Aptevo Therapeutics Inc. APVO | Ayrton Capital LLC | 19,897 10.000% | 19,897 (New Position) | Filing History |
| 2025-07-08 2:11 pm Purchase | 2025-06-16 | 13G | Aptevo Therapeutics Inc. APVO | YA II PN, Ltd. | 19,880 9.990% | 19,880 (New Position) | Filing History |
| 2025-06-25 4:38 pm Unchanged | 2025-06-18 | 13G | Aptevo Therapeutics Inc. APVO | Mitchell P. Kopin | 0 0.000% | 0 (Unchanged) | Filing History |
| 2025-06-25 4:30 pm Purchase | 2025-06-18 | 13G | Aptevo Therapeutics Inc. APVO | BIGGER CAPITAL FUND L P | 15,833 9.950% | 15,278 (+2750.00%) | Filing History |
| 2025-06-23 4:08 pm Purchase | 2025-06-18 | 13G | Aptevo Therapeutics Inc. APVO | L1 Capital Global Opportunities Master Fund, Ltd. | 15,833 9.950% | 14,722 (+1325.00%) | Filing History |
| 2025-06-23 4:07 pm Purchase | 2025-04-26 | 13G | Aptevo Therapeutics Inc. APVO | L1 Capital Global Opportunities Master Fund, Ltd. | 1,111 0.700% | 1,111 (New Position) | Filing History |
| 2025-04-25 4:07 pm Unchanged | 2025-04-21 | 13G | Aptevo Therapeutics Inc. APVO | Mitchell P. Kopin | 0 0.000% | 0 (Unchanged) | Filing History |
| 2025-04-25 4:05 pm Purchase | 2025-04-21 | 13G | Aptevo Therapeutics Inc. APVO | L1 Capital Global Opportunities Master Fund, Ltd. | 1,169 7.590% | 400 (+51.99%) | Filing History |
| 2025-04-25 4:01 pm Purchase | 2025-04-21 | 13G | Aptevo Therapeutics Inc. APVO | L1 Capital Global Opportunities Master Fund, Ltd. | 769 4.990% | 214 (+38.50%) | Filing History |
| 2025-04-10 10:14 am Purchase | 2025-04-03 | 13G | Aptevo Therapeutics Inc. APVO | CVI Investments, Inc. | 556 6.200% | 556 (New Position) | Filing History |
| 2025-04-09 5:31 pm Unchanged | 2025-04-03 | 13G | Aptevo Therapeutics Inc. APVO | Mitchell P. Kopin | 0 0.000% | 0 (Unchanged) | Filing History |
| 2025-04-08 8:00 pm Purchase | 2025-04-03 | 13G | Aptevo Therapeutics Inc. APVO | BIGGER CAPITAL FUND L P | 556 6.200% | 556 (New Position) | Filing History |
| 2025-04-07 4:51 pm Purchase | 2025-04-02 | 13G | Aptevo Therapeutics Inc. APVO | L1 Capital Global Opportunities Master Fund, Ltd. | 556 6.210% | 556 (New Position) | Filing History |
| 2025-02-10 6:58 pm Unchanged | 2024-12-31 | 13G | Aptevo Therapeutics Inc. APVO | Hudson Bay Capital Management LP | 213 4.990% | 0 (Unchanged) | Filing History |
| 2025-02-10 4:24 pm Purchase | 2024-12-31 | 13G | Aptevo Therapeutics Inc. APVO | Hudson Bay Capital Management LP | 213 4.990% | 213 (New Position) | Filing History |